|
|
Volumn 18, Issue 10, 2012, Pages 1446-
|
|
Companies wager high on cd38-targeting drugs for blood cancer
a
a
NONE
|
|
Author keywords
[No Author keywords available]
|
|
Indexed keywords
ANTINEOPLASTIC AGENT;
CD38 ANTIGEN;
CD38 PROTEIN, HUMAN;
DARATUMUMAB;
MEMBRANE PROTEIN;
MONOCLONAL ANTIBODY;
DRUG INDUSTRY;
HEMATOLOGIC DISEASE;
HUMAN;
IMMUNOLOGY;
METABOLISM;
NOTE;
ANTIBODIES, MONOCLONAL;
ANTIGENS, CD38;
ANTINEOPLASTIC AGENTS;
DRUG INDUSTRY;
HEMATOLOGIC NEOPLASMS;
HUMANS;
MEMBRANE GLYCOPROTEINS;
|
|
EID: 84872018620
PISSN: 10788956
EISSN: 1546170X
Source Type: Journal
DOI: 10.1038/nm1012-1446a Document Type: Note |
|
Times cited : (6)
|
|
References (0)
|